
Elizabeth A. Burkhart
Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )
| Most Active Art Unit | 1715 |
| Art Unit(s) | 1762, 1715, 1792 |
| Total Applications | 919 |
| Issued Applications | 503 |
| Pending Applications | 11 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5304381
[patent_doc_number] => 20090299033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/485998
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23073
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20090299033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12485998
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/485998 | Methods and compositions for F-18 labeling of proteins, peptides and other molecules | Jun 16, 2009 | Issued |
Array
(
[id] => 9273052
[patent_doc_number] => 08636978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Cyclized NGR peptide compounds, compositions, and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 13/000543
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6612
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000543 | Cyclized NGR peptide compounds, compositions, and methods of their use | Jun 14, 2009 | Issued |
Array
(
[id] => 8490274
[patent_doc_number] => 20120289681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'CONJUGATES OF CELL-PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT'
[patent_app_type] => utility
[patent_app_number] => 13/143309
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8117
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143309 | CONJUGATES OF CELL-PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT | Jun 7, 2009 | Abandoned |
Array
(
[id] => 5403469
[patent_doc_number] => 20090238783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'TREATMENT AND COMPOSITION FOR ACHIEVING SKIN ANTI-AGING BENEFITS BY CORNEUM PROTEASE ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 12/479079
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8605
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12479079
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/479079 | Treatment and composition for achieving skin anti-aging benefits by corneum protease activation | Jun 4, 2009 | Issued |
Array
(
[id] => 6646164
[patent_doc_number] => 20100228012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'PENDANT FATTY ACID IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/478531
[patent_app_country] => US
[patent_app_date] => 2009-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9776
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20100228012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12478531
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478531 | PENDANT FATTY ACID IMAGING AGENTS | Jun 3, 2009 | Abandoned |
Array
(
[id] => 5495299
[patent_doc_number] => 20090263327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/476169
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10886
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263327.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476169 | MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS | May 31, 2009 | Abandoned |
Array
(
[id] => 6355275
[patent_doc_number] => 20100022449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'RECEPTOR-AVID EXOGENOUS OPTICAL CONTRAST AND THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/470310
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19596
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12470310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470310 | RECEPTOR-AVID EXOGENOUS OPTICAL CONTRAST AND THERAPEUTIC AGENTS | May 20, 2009 | Abandoned |
Array
(
[id] => 8841064
[patent_doc_number] => 20130136691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'GASTRIN RELEASING PEPTIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/993620
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 111278
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993620
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993620 | GASTRIN RELEASING PEPTIDE COMPOUNDS | May 18, 2009 | Abandoned |
Array
(
[id] => 6006994
[patent_doc_number] => 20110059025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'IN VIVO IMAGING'
[patent_app_type] => utility
[patent_app_number] => 12/990217
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12737
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990217 | IN VIVO IMAGING | Apr 30, 2009 | Abandoned |
Array
(
[id] => 9957378
[patent_doc_number] => 09005577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Substrate based PET imaging agents'
[patent_app_type] => utility
[patent_app_number] => 12/433211
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27120
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12433211
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433211 | Substrate based PET imaging agents | Apr 29, 2009 | Issued |
Array
(
[id] => 5472964
[patent_doc_number] => 20090246130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/433212
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 52931
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433212
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433212 | Methods and compositions for F-18 labeling of proteins, peptides and other molecules | Apr 29, 2009 | Issued |
Array
(
[id] => 6367457
[patent_doc_number] => 20100074844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Cyclopeptides Containing RGD Mimetics As Imaging Markers For Integrins'
[patent_app_type] => utility
[patent_app_number] => 12/433258
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23102
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433258 | Cyclopeptides containing RGD mimetics as imaging markers for integrins | Apr 29, 2009 | Issued |
Array
(
[id] => 9388777
[patent_doc_number] => 08685371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Agents for detecting and imaging cell death'
[patent_app_type] => utility
[patent_app_number] => 12/989310
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 16235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989310 | Agents for detecting and imaging cell death | Apr 28, 2009 | Issued |
Array
(
[id] => 7818747
[patent_doc_number] => 20120065367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Radioactively Labeled Substance'
[patent_app_type] => utility
[patent_app_number] => 13/266249
[patent_app_country] => US
[patent_app_date] => 2009-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13332
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065367.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266249
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266249 | Radioactively Labeled Substance | Apr 27, 2009 | Abandoned |
Array
(
[id] => 6235005
[patent_doc_number] => 20100266709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Compositions and Methods for Treating Burns'
[patent_app_type] => utility
[patent_app_number] => 12/429169
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21031
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429169 | Compositions and Methods for Treating Burns | Apr 22, 2009 | Abandoned |
Array
(
[id] => 5551775
[patent_doc_number] => 20090285761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Renal Function Analysis Method and Apparatus'
[patent_app_type] => utility
[patent_app_number] => 12/425827
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11289
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285761.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425827 | Renal Function Analysis Method and Apparatus | Apr 16, 2009 | Abandoned |
Array
(
[id] => 8577249
[patent_doc_number] => 08343458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Probes for in vivo targeting of active cysteine proteases'
[patent_app_type] => utility
[patent_app_number] => 12/418116
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 13
[patent_no_of_words] => 15590
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12418116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/418116 | Probes for in vivo targeting of active cysteine proteases | Apr 2, 2009 | Issued |
Array
(
[id] => 5534433
[patent_doc_number] => 20090234221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'RESPONSIVE PARAMAGNETIC MRI CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/418155
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9734
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234221.pdf
[firstpage_image] =>[orig_patent_app_number] => 12418155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/418155 | Responsive paramagnetic MRI contrast agents | Apr 2, 2009 | Issued |
Array
(
[id] => 6270205
[patent_doc_number] => 20100254912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity'
[patent_app_type] => utility
[patent_app_number] => 12/384391
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6221
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254912.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384391
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384391 | Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity | Apr 2, 2009 | Issued |
Array
(
[id] => 6070055
[patent_doc_number] => 20110044905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'OXYTOCIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 12/933858
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5651
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933858 | Oxytocin analogues | Mar 29, 2009 | Issued |